Teuvo Lj Tammela
Overview
Explore the profile of Teuvo Lj Tammela including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siltari A, Murtola T, Kausz J, Talala K, Taari K, Tammela T, et al.
Acta Oncol
. 2023 Nov;
62(12):1898-1904.
PMID: 37971326
Background: Concerns have been expressed over the safety of testosterone replacement therapy (TRT) in men with late-onset hypogonadism (LOH). Previous studies have shown controversial results regarding the association of TRT...
2.
Huynh-Le M, Fan C, Karunamuni R, Walsh E, Turner E, Athene Lane J, et al.
Cancer Epidemiol Biomarkers Prev
. 2020 Jun;
29(9):1731-1738.
PMID: 32581112
Background: A polygenic hazard score (PHS), the weighted sum of 54 SNP genotypes, was previously validated for association with clinically significant prostate cancer and for improved prostate cancer screening accuracy....
3.
Kilpelainen T, Talala K, Taari K, Raitanen J, Kujala P, Pylvalainen J, et al.
Eur J Cancer
. 2020 Apr;
130:204-210.
PMID: 32229417
Background: In prostate cancer (PCa), lower education level is associated with less screening, more advanced stage at diagnosis and worse survival. The aim of this study was to estimate the...
4.
Rantapero T, Wahlfors T, Kahler A, Hultman C, Lindberg J, Tammela T, et al.
Genes (Basel)
. 2020 Mar;
11(3).
PMID: 32183364
Germline variants in DNA repair genes are associated with aggressive prostate cancer (PrCa). The aim of this study was to characterize germline variants in DNA repair genes associated with lethal...
5.
Murtola T, Vihervuori V, Lahtela J, Talala K, Taari K, Tammela T, et al.
Br J Cancer
. 2018 Mar;
118(9):1248-1254.
PMID: 29563633
Background: Diabetic men have lowered overall risk of prostate cancer (PCa), but the role of hyperglycaemia is unclear. In this cohort study, we estimated PCa risk among men with diabetic...
6.
Seibert T, Fan C, Wang Y, Zuber V, Karunamuni R, Parsons J, et al.
BMJ
. 2018 Jan;
360:j5757.
PMID: 29321194
Objectives: To develop and validate a genetic tool to predict age of onset of aggressive prostate cancer (PCa) and to guide decisions of who to screen and at what age....
7.
Neupane S, Steyerberg E, Raitanen J, Talala K, Pylvalainen J, Taari K, et al.
Int J Urol
. 2017 Dec;
25(3):270-276.
PMID: 29224236
Objectives: To identify the prognostic factors of prostate cancer death among patients enrolled in a Finnish prostate cancer screening trial. Methods: Data on TNM stage, Gleason score, serum prostate-specific antigen...
8.
Kaapu K, Murtola T, Talala K, Taari K, Tammela T, Auvinen A
Br J Cancer
. 2016 Oct;
115(11):1289-1295.
PMID: 27755533
Background: Protective effects have been suggested for digoxin against prostate cancer risk. However, few studies have evaluated the possible effects on prostate cancer-specific survival. We studied the association between use...
9.
Pashayan N, Pharoah P, Schleutker J, Talala K, Tammela T, Maattanen L, et al.
Br J Cancer
. 2015 Aug;
113(7):1086-93.
PMID: 26291059
Background: We derived estimates of overdiagnosis by polygenic risk groups and examined whether polygenic risk-stratified screening for prostate cancer reduces overdiagnosis. Methods: We calculated the polygenic risk score based on...
10.